/PRNewswire/ ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients.
/PRNewswire/ ChromaCode, Inc., which brings accessible and affordable insights to labs, patients and physicians through its innovative High Definition PCR.
ChromaCode Named Finalist in XPRIZE Rapid Covid Testing Competition
XPRIZE imagines a future where anyone, anywhere, can receive a fast, frequent, cheap and easy COVID-19 test
News provided by
Share this article
Share this article
CARLSBAD, Calif., Dec. 22, 2020 /PRNewswire/ ChromaCode, Inc. today announced that the company has been named a finalist in the $6 million XPRIZE Rapid Covid Testing competition, a six-month competition to develop faster, cheaper and easier-to-use COVID-19 testing methods at scale. Fast, affordable and accessible testing is crucial to containing the COVID-19 pandemic and safely reopening schools, businesses and other vital institutions around the world, said Anousheh Ansari, CEO of XPRIZE.